Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04051294 · ClinicalTrials.gov registry record · NA
The Effect of Kombucha on Blood Sugar Levels in Humans
A NA study of Blood Sugar; High and Glucose, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT04051294: Completed NA study of Blood Sugar; High and Glucose, sponsored by University of Missouri-Columbia.
NCT04051294 is a NA study of Blood Sugar; High and Glucose that has completed, run by University of Missouri-Columbia. The registered enrollment target is 33 participants, roughly in line with the 32-participant average among 5 other Blood Sugar; High trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04051294, a NA study of Blood Sugar; High and Glucose, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
As a phase 0 clinical trial, we will learn how kombucha influences glucose metabolism in humans.
Primary Outcome
Blood drawn following a 10-12 hour fast.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Commercial kombucha tea
- DIETARY_SUPPLEMENT Brewed kombucha tea
- OTHER Control: Tea
- OTHER Control: Water
Study Locations (1)
Missouri
- University of Missouri - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2019-01-03 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
What the finished NCT04051294 record still lists
NCT04051294 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, roughly in line with the 32-participant average among 5 other Blood Sugar; High trials with a reported enrollment target.
The record links to 3 conditions, with Blood Sugar; High appearing as the primary indexed condition, and to 4 interventions - of which Commercial kombucha tea is the first listed.
NCT04051294 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT04051294 about?
NCT04051294 is a clinical study titled "The Effect of Kombucha on Blood Sugar Levels in Humans". As a phase 0 clinical trial, we will learn how kombucha influences glucose metabolism in humans.
What is the current status of trial NCT04051294?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2019-01-03. Estimated completion is 2022-09-30.
What conditions does trial NCT04051294 study?
This clinical trial studies the following conditions: Blood Sugar; High, Glucose, Glucose Metabolism Disorders (Including Diabetes Mellitus).
What interventions are being tested in trial NCT04051294?
The interventions under investigation include: Commercial kombucha tea (DIETARY_SUPPLEMENT), Brewed kombucha tea (DIETARY_SUPPLEMENT), Control: Tea (OTHER), Control: Water (OTHER).
Who is sponsoring clinical trial NCT04051294?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04051294 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Sugar; High
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
FELLAShip to Better Health
RECRUITING · NA
-
Circadian Health Regulation and Optimization for Rejuvenation Outcomes
ACTIVE NOT RECRUITING · NA
-
Preliminary Effect of Food Processing and Sweeteners on Glycemic and Metabolic Measures
COMPLETED · NA
-
Barley Beta-glucan, Glycemic Control, and Appetite
COMPLETED · NA
-
The Attenuating Effect of Soluble Fiber Consumption on Postprandial Glycemia in Humans
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI